Bayer sales before and after Monsanto. Crop science. Consumer health. Source: the company. World population. Source: U. Department of Economic and Social Affairs.
Bayer estimated pharmaceutical revenue. Other pharma. Drugs in the pipeline. Source: Bernstein analysis of company data. Source: Bayer calculations based on company data.
Share price and offers. Per share:. May July Bayer offer. July 14 Details of the deal. May 23 July 14 Sept. Chr y sler. O r ange. Deutsche Telekom. S chering. Han s on. Dresdner Bank. Company forecast 4Q June 7 Bayer closes its Monsanto acquisition. May 29, U. June 7: Bayer closes Monsanto acquisition. Those who had helped Hitler to power and provided the technical know-how for his wars of aggression and the Holocaust were back in control of the industry.
The Bayer executive Fritz ter Meer typifies the bounce back. An executive of IG for many years, the most senior scientist on its supervisory board and the chairman of its technical committee, he had become a Nazi Party member in and was the executive responsible for the construction of the IG Farben factory in Auschwitz, in which tens of thousands of slave labourers met their deaths. Ter Meer's own visits to Auschwitz and the detailed reports he received made it inconceivable that he did not have a clear picture of what was occurring.
The Nuremberg War Crimes Tribunal found him guilty of plunder, slavery and mass murder. But despite being found the most culpable of the men who, in the words of Chief Prosecutor, "made war possible By he had become the chairman of the supervisory board of Bayer, a post he held until Even today Bayer continues to honour this convicted mass murderer.
On All Saints Day , for instance, the corporation is known to have laid a large memorial wreath on ter Meer's grave in Krefeld-Uerdingen, Germany. Yet for decades Bayer refused to pay compensation to its surviving slave labourers. Only after international protests did it eventually agree to pay damages - more than 50 years after the end of the war.
Bayer continued to grow in the post-war period, eventually becoming bigger than the whole of IG Farben even at its zenith. Even as part of IG Farben, Bayer had maintained its strength in pharmaceuticals. In fact, scientific experiments had been done specifically on behalf of Bayer in Auschwitz and other concentration camps. IG had footed the bill for the research of Josef Mengele, Auschwitz-Birkenau's infamous "Angel of Death", and some of his experiments utilised germs and pharmaceuticals provided by Bayer.
Wilhelm Mann, whose father had headed Bayer's pharmaceutical department, wrote as head of IG's powerful pharmaceutical committee to an SS contact at Auschwitz: "I have enclosed the first cheque.
Dr Mengele's experiments should, as we both agreed, be pursued. Heil Hitler. Prisoners died as a result of many of these experiments.
Vetter was convicted of war crimes in and was executed in but Bayer's role only emerged later. In the Auschwitz files correspondence was discovered between the camp commander and Bayer. It dealt with the sale of female prisoners for experimental purposes and involved haggling over the price. One exchange notes: "The experiments were performed. All test persons died. We will contact you shortly about a new shipment at the same price. It is clear that the experiments in the concentration camps with IG preparations only took place in the interests of the IG, which strived by all means to determine the effectiveness of these preparations.
They let the SS deal with the - shall I say - dirty work in the concentration camps. It was not the IG's intention to bring any of this out in the open, but rather to put up a smoke screen around the experiments so that Not the SS but the IG took the initiative for the concentration camp experiments.
In the post-war years Bayer grew to become the third largest pharmaceutical company in the world. In the mids Bayer was one of the companies which sold a product called Factor VIII concentrate to treat haemophilia.
Factor VIII turned out to be infected with HIV and in the US alone, it infected thousands of haemophiliacs, many of whom died in one of the worst drug-related medical disasters ever. But it was only in that the New York Times revealed that Bayer had continued producing and selling this infected product to Asia and Latin America after February when a safe product had become available, in order to save money. Dr Sidney M. Wolfe, who investigated the scandal, commented, "These are the most incriminating internal pharmaceutical industry documents I have ever seen.
In the early s Bayer is said to have placed patients at risk of potentially fatal infections by failing to disclose crucial safety information during a trial of the antibiotic Ciproxin. Up to people underwent surgery using Ciproxin without doctors being informed that studies as early as showed Ciproxin reacted badly with other drugs, seriously impairing its ability to kill bacteria.
Germany's health minister accused Bayer of sitting on research documenting Baycol's lethal side-effects for nearly two months before the government in Berlin was informed.
It is thought to have been partly in response to the impact of the Baycol scandal that Bayer bought the rival crop sciences unit of French company Aventis, which had absorbed part of Hoechst, in October Technical Rankings. Fundamental Rankings. Stock Screener Home. MarketScreener tools. Dynamic chart. Our Services. MarketScreener Portfolios. Add to my list. Markets and indexes - Prime Standard. DE - Datastream Code :.
In partnership with Allbrands. Head of Bayer's crop unit quits in aftermath of profit rout. More Must read. Sector Other Pharmaceuticals. Connections : Bayer AG. All rights reserved. Show password. Add to my list Report. Johnson Matthey shares plunge as firm exits battery materials business. Business Summary. Bayer AG is a German-based life science company. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others.
The company is focusing on their oncology platform o Targeted Alpha Therapies for treating prostate cancer. Th Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others.
0コメント